Warwick Medical School is about to begin a new phase of research into the effects of Vitamin B12 on pregnant women following an award of £800,000 from the Medical Research Council (MRC).
- Medicine - 18:01 Sharing ideas on health and the universe at Liverpool TEDx
- Medicine - 18:00 Welsh experts unite in new bid to tackle cancer
- Life Sciences - 17:03 UCLA and UCI awarded $8 million grant to launch collaborative stem cell clinic
- Astronomy - 17:00 Hinode Satellite Captures X-ray Footage of Solar Eclipse
- Medicine - 16:03 In Malaysian prison, Aishwarya Vijay gains greater insight into the problem of addiction
- Business - 15:01 How effective are we in tackling water security?
- Computer Science - 15:00 'Eye in the sky' will bypass Internet traffic jams
- Study of Religions - 15:00 Return of the new gods: Jedis, auras and online witch schools
- Life Sciences - 15:00 Gene that once aided survival in the Arctic is found to have negative impact on health today
- Business - 14:03 Becker Friedman Institute announces two new research fellows
- Administration - 14:02 Password refresh campaign to launch this fall
- Study of Religions - 14:01 CofE clergy concerned with protecting the welfare budget
- Medicine - 14:01 New Health at Work Policy Unit launched by Lancaster University’s Work Foundation
- Arts - 13:03 Stanford family objects tell the story of tragic loss and a lasting institution
- Earth Sciences - 11:00 Mumbai
- Medicine - 10:01 New support method improves health of kidney disease patients
Could Vitamin B12 hold key to reducing diabetes in pregnant women?
Warwick, in partnership with the University of Southampton and King Edward Memorial Hospital in Pune, India, hopes to recruit 4,500 women in the early stages of pregnancy so they can study whether micro nutrients such as Vitamin B12 reduce the risk of developing gestational diabetes (GDM).
Numbers of mothers affected by GDM are rapidly rising, and with it, all manner of additional health complications for both the mother and the baby. In seven out of ten cases, mothers who have GDM go on to develop full blown diabetes. And babies born to women with GDM are at a higher risk of developing obesity and diabetes as an adult.
Ponnusamy Saravanan , Associate Clinical Professor of Diabetes, Endocrine & Metabolism at Warwick Medical School and George Eliot Hospital, explained how this new research would build on earlier studies which indicate that the risk of diabetes is determined in the womb:
“This research will study pregnant women and follow the growth and development of their babies. The current research is funded until childbirth and we hope to closely follow up both mothers and baby beyond.
“Our earlier research in India shows that mothers with low Vitamin B12 levels gave birth to babies with features suggestive of them developing diabetes and cardiovascular diseases soon after birth and at 6 years.”
He believes that the micro-nutrients (vitamins) in a woman’s diet fundamentally influence how the DNA functions, and this gene-diet interaction determines, at least in part, whether you are going to be more prone to being overweight as an adult. So this very early ‘in-utero’ stage is seen as critical in mapping out your adult health.
The first stage of the research begins next month with recruitment of women in the Coventry and Warwickshire areas who are in the extremely early stages of pregnancy. This group will have equal number of mothers from South Asian and Caucasian background. The results will also provide an insight into why South Asian women have a far higher prevalence for developing GDM.
Ultimately, Saravanan would like to see a point when Vitamin B12 becomes a nationally recommended supplement for pregnant women in the same way that Folic Acid is: “Vitamin B12 is relatively cheap to produce and distribute, and if the research provides evidence to back up the suggested long-term health benefits, Vitamin B12 could be key in preventative health care of the future.”
Saravanan concluded: “We are, without doubt, facing an obesity epidemic in this country. With each generation we are becoming more overweight and developing more cases of associated conditions such as diabetes and heart disease.
“We need to establish more ‘primordial prevention’ which means taking preventive action before these conditions develop, to improve our nation’s future health and reduce the cost of treatment for the NHS, and our research is contributing to that goal.”
Last job offers
- Business - 23.10
Wissenschaftlicher Referent für Wirtschaftspolitikberatung (m/w)
- Environmental Sciences - 23.10
Post-doc or Senior Research Scientist for Combustion Aerosols
- Life Sciences - 23.10
PhD position on Toxoplasma Cell Biology Research
- Business - 20.10
Dozent / Dozentin mit Forschungserfahrung
- Business - 20.10
Doktorandin / Doktoranden in den Bereichen Raum und Mobilität oder Energie und Mobilität
- Business - 16.10
Assistant Professor in Economics
- Medicine - 23.10
Sydney Catalyst Professor / associate Professor in Translational Cancer Research a Professor / associate...
- Social Sciences - 23.10
Assistant / Associate Professor in Globalisation and Development at the Faculty of Arts and Social Sciences,...
- Business - 19.9
UniversitätsprofessorIn für die Stiftungsprofessur "Industrielle Energiesysteme"
- Literature - 17.9
Universitätsprofessur für Anglistische Sprachwissenschaft
- Medicine - 24.10
Universitätsprofessur W3 für Chirurgie und die Leitung der Klinik für Allgemeine, Viszerale und Tumor-Chirurgie...
- Business - 24.10
Professorship (W3) in Economics
- Life Sciences - 24.10
Chair in Global Change Biology
- Medicine - 24.10
Chair in Health Policy and Management and Director of the Health Services Management Centre. 30845
- Business - 24.10
Professor & Director of Graduate Studies in Industrial Design
- Mathematics - 23.10
Applied Mathematics - Assistant, Associate or Full Professor (AA8801)